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Abstract
ePPOC is a program that aims to improve services and outcomes for people experiencing persistent pain.
It involves specialist pain services collecting a standard set of information to measure outcomes for their
patients as a result of treatment. Pain services use the information to triage, monitor and plan treatment
for individual clients, and also send non-identifiable information to ePPOC for analysis. The results of
these analyses are fed back to participating services every six months, allowing pain management
services to assess their results, and compare their patients, services and outcomes to other pain
management services. ePPOC also uses the information collected by services for national benchmarking
and to develop a coordinated approach to research into the management of chronic pain in Australasia.
ePPOC is an initiative of the Faculty of Pain Medicine, established with funding from the New South Wales
Ministry of Health, and supported by key stakeholder bodies. It was launched in 2013 with a small number
of pain management services trialling the measures and processes. All other pain management services
throughout Australia and New Zealand are now able to participate.
PaedePPOC addresses the differing needs of the paediatric pain management sector. This program
allows collection of data items and assessment tools specific to the needs of children, adolescents and
their parents.
This report presents data collected by participating pain management units during 2018. Sixty seven
adult and nine paediatric pain management services contributed data for this report.
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The electronic Persistent Pain Outcomes
Collaboration (ePPOC)
ePPOC is a program that aims to improve services and outcomes for people experiencing persistent pain.
It involves specialist pain services collecting a standard set of information to measure outcomes for their
patients as a result of treatment. Pain services use the information to triage, monitor and plan treatment
for individual clients, and also send non-identifiable information to ePPOC for analysis. The results of
these analyses are fed back to participating services every six months, allowing pain management
services to assess their results, and compare their patients, services and outcomes to other pain
management services. ePPOC also uses the information collected by services for national benchmarking
and to develop a coordinated approach to research into the management of chronic pain in Australasia.
ePPOC is an initiative of the Faculty of Pain Medicine, established with funding from the New South Wales
Ministry of Health, and supported by key stakeholder bodies. It was launched in 2013 with a small number of
pain management services trialling the measures and processes. All other pain management services
throughout Australia and New Zealand are now able to participate.
PaedePPOC addresses the differing needs of the paediatric pain management sector. This program allows
collection of data items and assessment tools specific to the needs of children, adolescents and their parents.

This report
This report presents data collected by participating pain management units during 2018. Sixty seven
adult and nine paediatric pain management services contributed data for this report (see Appendix A).
The map below shows the locations of these services.
This report includes;
• Information on over 30,000 patients
• Information on patients’ demographic
and clinical characteristics and the
care they received
• Outcomes for adult and paediatric
patients who completed an episode of
treatment
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Pain management services participating in
ePPOC
The services submitting data for this report were both public and private services located in:
•
•
•
•
•
•

New South Wales (18 adult and 3 paediatric services)
Victoria (17 adult and 2 paediatric services)
Queensland (6 adult and 2 paediatric services)
Western Australia (3 adult services)
South Australia (3 adult and 1 paediatric services)
New Zealand (20 adult and 1 paediatric services).

Since the first ePPOC report in 2014, the number of data-submitting services has increased from 12 to 76.
Figure 1 – Number of data submitting services, 2014-2018
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Adults referred for pain management
Demographic profile
Adult pain management services contributed data for 31,530 patients during 2018. Of these patients,
57% were female, with an average age of 51 years at the time of referral. Males were slightly younger on
average at 50 years. The distribution by gender and age is shown in Figure 2.
Figure 2 – Age at referral and gender distribution of patients
25%
20%
15%
10%
5%
0%

<18

18-24

25-34

35-44
Male

45-54

55-65

65-74

75-84

85+

Female

Most patients were born in Australia (53%) or New Zealand (22%) and 4% identified as being of
Aboriginal and/or Torres Strait Islander origin. A relatively small proportion (4%) required an interpreter
and 8% required assistance with written or spoken communication. Most patients were referred to the
pain management service by a general practitioner or nurse practitioner (53%).
The majority of patients were unable to work, either due to pain (39%) or another condition (12%). 18%
of episodes involved a compensation claim. Figure 3 shows the work status of patients at referral to the
pain management service.
Figure 3 – Work status of patients at referral
Unable to work (due to pain)

39%

Not working by choice

17%

Working full-time

17%

Working part-time

13%

Unable to work (not due to pain)
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ePPOC Data Report 2018

10%

20%

30%

40%

50%

Page | 4

Clinical characteristics at referral
Most patients referred to pain management services completed a questionnaire prior to their first
appointment with the service. These questionnaires asked patients about their pain, medication and
health care utilisation, and included standard assessment tools which examined mood, cognition,
physical function and pain interference. More detailed information regarding these tools is provided in
Appendix B.
21,364 of these initial questionnaires were completed, providing a picture of the health and clinical
characteristics of patients referred for specialist pain management.

Pain
Table 1 – Patient-reported cause of pain

40% of patients had experienced their pain for more
than five years, and most (86%) described their pain
as ‘always present’. The events that led to the
patients’ pain are shown in Table 1.

Precipitating event
Injury at work/school
No obvious cause
Injury at home
Related to another illness
Motor vehicle crash
Injury in another setting
After surgery
Related to cancer
Other

The regions where pain is at its worst are shown in
Figure 4, with the back being the most common
(43% of patients identified this as the most painful
site). 14% of patients had pain in one region only,
with the remainder identifying multiple regions, as
shown in Figure 5.

Figure 4 – Site of patient’s main pain
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Figure 5 – Number of pain sites
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The Brief Pain Inventory (BPI) was used to assess the intensity of pain and its interference in activities of
daily living over the past week. Figure 6 shows that at referral, nearly 1 in 2 people rated their pain as
severe, and over 60% reported that it severely interfered with daily activities.
Figure 6 - Proportion of people with severe, moderate and mild pain and pain interference

Pain severity

44%

Interference

39%

62%

0%

20%

17%

25%

40%
Severe
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80%
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13%

= 6.9

100%
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Comorbid conditions
The patient questionnaires included a
list of medical conditions, and asked
patients to indicate which (if any) they
experienced in addition to their pain.
39% of patients reported that they had
a mental health condition, with the
majority of these people experiencing
depression. The percent of patients
with each of these conditions is shown
in Table 2.
The clinical complexity of people
referred to pain management services
is further illustrated in Figure 7, which
shows that most people experience at
least one other condition in addition to
their pain.

ePPOC Data Report 2018

Table 2 - Comorbid conditions
Medical condition
Mental health condition
Depression
Anxiety
PTSD
Arthritis
Heart and circulation problems
High blood pressure
High cholesterol
Muscle, bone and joint problems other than arthritis
Digestive problems
Respiratory problems
Diabetes
Neurological problems
Liver, kidney and pancreas problems
Thyroid problems
Cancer
Other medical problems

Percentage
38.8
32.7
18.3
6.1
30.5
23.5
15.3
4.4
20.8
17.9
15.8
7.3
6.3
5.3
5.1
3.6
14.5
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Figure 7 – Distribution of patients by number of comorbidities
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Body Mass Index
Figure 8 – Patient BMI
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39%

Underweight (<18.5)

26%

32%

Normal weight (18.5 to
24.99)
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29.99)

The average Body Mass Index
(BMI) of patients at referral was
29.5 (SD=7.6) which lies in the
Overweight category, but
bordering on Obese. The
percentage of patients in each
BMI category is show in Figure 8.

Obese (>=30)

Mood
The Depression Anxiety and Stress Subscale (short form) was used to assess the mental health of people
referred for specialist pain management. Figure 9 shows that 40% of people were experiencing
extremely severe or severe depression, and over one third reported severe or extremely severe anxiety
and/or stress.
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Figure 9 - The proportion of people reporting depression, anxiety and stress at referral
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Cognition
The Pain Self-Efficacy Questionnaire (PSEQ) assesses a patient’s belief that he or she can perform a range
of activities despite their pain.
The average score on the PSEQ following referral to the pain services was 21.4 (SD=13.0), a score
classified as ‘Moderate’ but bordering on severe impairment (identified by scores less than 20). Figure 10
shows that one in two people reported that pain severely impaired their belief that they could perform
these daily activities.
Figure 10 - The proportion of people reporting severe, moderate and mildly impaired pain self-efficacy at referral
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Patients also completed the Pain Catastrophising Scale (PCS), which measures thoughts and feelings
related to pain. The average score on the PCS at referral was 27.5 (SD=13.9), a score classified as
‘Moderate’, but with just under 50% of people reporting severe pain catastrophising (Figure 11).
Figure 11 - The proportion of people reporting severe and high levels of pain catastrophising at referral
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Medication use
At referral to the service, 59% of patients were taking opioid medication on more than two days per
week. The average daily oral morphine equivalent for patients using opioid medication was 62.9mg. On
average, patients were using medications from two of the seven major drug groups, identified by the
Faculty of Pain Medicine as of particular interest in pain management 1. The percentage of patients using
each of the drug groups is show in Figure 12.
Figure 12 – Percent of patients using each drug group at referral
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Health service utilisation
Patients reported how many times in the past three months they used various health services and had
diagnostic tests performed because of their pain (Table 3). These equate to, on average, one visit every
week for pain-related reasons.
Table 3 – Patient use of health services

Health service
General practitioner
Medical specialist
Health professionals other than doctors
Hospital emergency department
Hospital admission
Diagnostic tests

Mean
4.7
1.4
4.7
0.5
0.3
1.4

These are opioids, paracetamol, NSAIDS, antidepressants, anticonvulsants, benzodiazepines and
medicinal cannabinoids.
1
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The episode of care
The median wait time for a patient to start an episode of care at a pain management service was 55 days
(average = 92 days). This reflects the time from when the pain service receives a referral, to the patient’s
first clinical contact. Over two thirds of people were seen within 3 months of the service receiving the
referral.
Most episodes of care extended from 1 to 6 months (median = 134 days) and patients typically received
an average of 25 hours of treatment during that period.

Patient outcomes
Pain management units provided information on the outcomes of 5,408 patients who completed their
episode of care during 2018.
At the end of the episode, patients were asked to compare how they would describe themselves now
(overall and physical abilities) compared to before receiving treatment. Patients responded using a Likert
scale which ranged from -3 (very much worse) to +3 (very much better). Responses are shown in Figure
13, with almost 3 in 4 patients reporting that they had improved following pain management.
Approximately 1 in 5 reported no change, and 8-9% rated themselves as worse.
Figure 13 – Global rating of change at episode end – overall and physical
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Pain, mood and cognitions
After receiving pain management, a large proportion of people reported clinically significant
improvement 2 in the severity of their pain and its interference in their daily activities, as well as improved
mood and pain-related cognitions (see Table 4).

In assessing outcomes using the standard assessment tools, ePPOC has adopted guidelines for
determining whether a change is clinically significant, that is, what change in score represents a
meaningful difference to the patient. These guidelines are detailed in Appendix B.

2
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Table 4 - Proportion of people who made clinically significant improvement (CSI) from referral to episode end

Domain

People who report CSI

Pain
- Pain severity
- Pain interference
Mood
- Depression
- Anxiety
- Stress
Cognitions
- Pain catastrophising
- Pain self-efficacy

33%
65%
62%
47%
63%
58%
53%

Over time, the proportion of people who report clinically significant improvement has increased across all
domains. This is shown in Figure 14, which displays improvement in 2018 compared to 2015.
Figure 14 – Percentage of patients reporting clinically significant improvement, 2015 vs. 2018
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Medication use
Following treatment at a pain management service, many people made improvements in their use of
medications. In particular, of the people who were using opioid medication at referral:
•
•
•
•

29% no longer used opioid medication frequently (more than two days per week)
The average daily morphine equivalent reduced from 57mg to 42mg per day
45% of people were able to at least halve their opioid dose
41% of people who were using high doses of opioid at referral (>40mg per day) were able to
reduce their dose by at least half following pain management.

ePPOC Data Report 2018
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Employment and work productivity
Almost one half (42%) of patients who completed an episode of care were unemployed due to pain at
referral. While the majority were still unemployed due to pain at the end of the episode, 1 in 3 people no
longer classified themselves in this way – they were either employed (full time or part time), seeking
employment, not working by choice or unable to work for a reason other than pain (see Figure 15).
Figure 15 – Work status at episode end for patients who were ‘unemployed due to pain’ at referral
Unable to work (due to pain)

68%
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12%
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80%

For those people who were working at referral, absenteeism and productivity improved following pain
management. Figure 16 shows that at referral, workers missed over 30% of their usual hours because of
pain, and rated impairment while working at 56%. After treatment this decreased to 19% missed hours
and 41% impairment.
Figure 16 - Absenteeism and productivity at referral compared to episode end
60
Referral

Episode end

55.8
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50
40.7

40
31.8
30
19.3

20
10
0

Work time missed due to pain

Impairment while working due to pain

Overall work impairment, taking into account absenteeism and impairment while at work, decreased
from 63% at referral to 46% following treatment at a pain management service.
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Children and adolescents referred for pain
management
Demographic profile
Participating paediatric pain management services contributed data for 803 patients during 2018. Of
these patients, 71% were female, with an average age of 12.8 years at the time of referral. Males were
younger on average at 11.6 years. The distribution by gender and age is shown in Figure 17.
Figure 17 – Age and gender distribution of patients
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60%
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Most patients were born in Australia (87%) and 5% identified as being of Aboriginal and/or Torres Strait
Islander origin. Patients were generally referred to the pain management service by a specialist
practitioner (66%).

Clinical characteristics at referral
Most children and their parents completed a questionnaire prior to their first appointment with the
service. These questionnaires asked children and parents about pain, medication and use of health care
services, and included standard assessment tools which examined pain severity, quality of life, disability,
pain-related worries and the impact of the child’s pain on the parent. More detailed information
regarding these tools is provided in Appendix C.
868 of these initial questionnaires were completed (427 completed by the child, 441 by the parent),
providing a picture of the health and clinical characteristics of patients following their referral to a
specialist paediatric pain management service. All information in this section is based on patient and/or
parent report.

ePPOC Data Report 2018
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Pain
Parents were asked how long their child’s pain had
been present, and 60% responded that their child
had experienced the pain for more than 12 months.
Most (67%) described the pain as ‘always present’.
The events thought to have caused the child’s pain
are shown in Table 6. 40% of parent’s reported that
the cause of their child’s pain was unknown.

Table 5 – Event precipitating the patient’s
pain
Precipitating event
No known cause
Injury
Illness
After surgery
Other

Regions where the main pain was experienced are
shown in Figure 18, with the back and head the
most common (17% each) followed by the
abdomen (16%). Just over one in four patients had
pain in one region only, with the remainder
identifying multiple regions (see Figure 19).
Figure 18 – Site of patient’s main pain
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Figure 19 – Number of pain sites
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Pain severity was assessed using the Brief Pain Inventory (BPI) in children aged eight years and above.
Young children aged 5-7 completed the Faces Pain Scale – Revised. Parents also rated their child’s pain
using the BPI. The average pain rating reported by child and parent at referral was 5.5 and 5.4 (moderate
severity), respectively, with one in three children and parents rating the pain as severe.
Figure 20 – Patient and parent ratings of pain severity
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Comorbid conditions
Parents were asked whether their child had a disability and/or other medical condition in addition to
their pain. The responses are shown in Table 6 below.
Table 6 - Percent of parents reporting disabilities and comorbidities
% of
Disabilities and comorbid conditions
patients
Disabilities
Sight impairment
5.8
Hearing impairment
2.4
Intellectual disability
3.5
Physical disability
9.3
Comorbid conditions
Chronic disease
21.4
Mental health condition
24.0
Cancer
1.3

Role functioning
The number of school days children missed in the previous fortnight (10 school days) as a result of their
pain increased with age, as shown in Figure 21.
Figure 21 – Days of school missed by age group
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3.0

3.0
2.5

2.0

2.0
1.5

1.0

1.0
0.5
0.0
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Quality of Life
Quality of life was assessed using the Paediatric Quality of Life Inventory (PedsQL) with both children and
parents rating the child’s quality of life. Total and subscale average scores at referral are shown in Table
8, with higher scores reflecting greater quality of life. Total scores below 69.7 and 65.4 for the child and
parent, respectively, indicate ‘at risk’ status for impaired quality of life. Over 85% of both parents and
children rated the child’s quality of life in this ‘at risk’ range.
Table 7 – Patient and parent quality of life scores
Domain
Psychosocial
Physical
Total score

Child
53.7
38.9
48.4

ePPOC Data Report 2018

Parent
51.0
38.4
46.5
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Disability
Children aged eight and older completed the Functional Disability Inventory (FDI) to assess the impact of
pain on the ability to complete 15 regular physical activities (such as walking, going to school, getting to
sleep). The average score for children was 23.1, reflecting moderate disability. The distribution of scores
by severity category is shown in Figure 22, indicating that over 4 in 5 children rated their functional
disability as either moderate or severe.
Figure 22 – Disability at referral by severity category
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Pain-related anxiety
Children aged 13 and older completed the pain-specific anxiety section of the Bath Adolescent Pain
Questionnaire. This asks questions assessing pain-related worries, such as “I avoid activities that cause
pain” and “When I have pain, I think something harmful is happening”. Responses range from Never to
Always, with higher scores indicating greater severity. Children scored an average of 15.9 in pain-specific
anxiety. The distribution of scores on this tool is shown below in Figure 23.
Figure 23 – Distribution of pain-related worry scores
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Medication use
Parents provided information regarding the medication their child was taking for pain and how
frequently each was used. The percent of patients taking each medication type daily or often is shown in
Figure 24 below.
Figure 24 – Percentage of patients using medication daily or often by medication type
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40%
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Health service utilisation
Parents reported how many times in the past three months their child had used various health services
and had diagnostic tests performed because of their pain, shown in Table 8. These equate to, on average,
more than one visit every week for pain-related reasons.
Table 8 – Paediatric patient use of health services
Health service
General practitioner
Medical specialist
Allied health professionals
Other therapist
Hospital emergency department
Hospital admission
Diagnostic tests
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Mean
3.3
2.9
3.1
1.4
1.3
0.4
2.0
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The episode of care
In paediatric services, the median wait time was 49 days (average = 65 days). This reflects the time from
when the pain service receives a referral, to the first clinical contact. 85% of people were seen within 3
months of the service receiving the referral.
Episodes of care tended to be longer in paediatric services (compared to adult pain services), with a
median episode length of 183 days.

Patient outcomes
Pain management units provided information on outcomes reported by 101 patients and 94 parents for
episodes that ended during 2018.

Pain and quality of life
Although the volume of outcomes is relatively small, a large proportion of children and adolescents (and their
parents) reported clinically significant improvement 3 after receiving pain management at specialist services (see

Table 9).

Table 9 – Paediatric patient outcomes
Percent of patients reporting a clinically significant
improvement
Pain Severity
Average pain
Worst pain
Health-related quality of life
Sleep
Overall
Functional disability

Patient rated

Parent rated

62%
42%

65%
53%

45%
76%
61%

39%
75%
na

Average pain improved in around 2 in 3 children, as did functional ability. An even higher proportion of
patients and parents reported clinically significant improvement in overall health-related quality of life,
with over 3 in 4 children improving.
There was also a reduction in the percentage of children whose scores on the PedsQL indicated impaired
quality of life: at referral 84% of children were classified as having impaired quality of life, however at the
end of the episode of care this proportion was 55%.
One in two adolescents reported an improvement of 30% or more in their pain-related anxiety.

In assessing outcomes using the standard assessment tools, ePPOC has adopted guidelines for
determining whether a change is clinically significant, that is, what change in score represents a
meaningful difference to the patient. These guidelines are detailed in Appendix C.

3
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Medication use
The change in frequent use of medications from referral to episode end is shown in Figure 25. With the
exception of opioids not containing codeine, there was a reduction in the use of medications used daily
or often.
Figure 25 – Medications used daily or often at referral compared to episode end
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Appendix A – Data submitting services
Adult pain management services
New South Wales

Victoria

Central Coast Integrated Pain Service
Concord Repatriation Hospital Pain Clinic
Greenwich Hospital Pain Management Service
Hunter Integrated Pain Service
Illawarra-Shoalhaven Chronic Pain Service
Lismore Hospital Pain Management Clinic
Liverpool Hospital Chronic Pain Service
Nepean Hospital Pain Management Unit
Orange Base Hospital Chronic Pain Clinic
Port Macquarie Chronic Pain Service
Prince of Wales Pain Management Department
Royal North Shore Hospital Pain Service
Royal Prince Alfred Pain Management Service
St George Pain Management Unit
St Vincent’s Hospital Pain Clinic
Sydney Spine and Pain Rehab
Tamworth Integrated Pain Service
Westmead Hospital Pain Service

Advance Healthcare
Austin Health
Barbara Walker Centre for Pain Management
Caulfield Pain Management and Research Centre
Dorset Rehabilitation Centre
Eastern Health Pain Management Service
Empower Rehab
Epworth Hospital
Goulburn Valley Chronic Pain Service
Latrobe Regional Hospital
Melbourne Health – Pain Management Services
Monash Health Pain Management
Northern Health Pain Assessment & Management
Service
Peninsula Health Chronic Pain Management Service
Precision Ascend Rehabilitation Centre
The Victorian Rehabilitation Centre
Western Health Pain Management

Queensland

New Zealand

Interventus Pain Specialists
North Queensland Persistent Pain Management
Service (Townsville Hospital)
Princess Alexandra Hospital – Metro South Health
Persistent Pain Management Service
St Vincent’s Private Hospital Brisbane
Sunshine Coast Persistent Pain Management
Service (Nambour Hospital)
The Wesley Hospital Brisbane

South Australia

Central Adelaide Local Health Network
Flinders Medical Centre Pain Management Unit
Northern Pain Rehabilitation Service

Western Australia

Fiona Stanley Hospital
PainCare
Sir Charles Gairdner Hospital
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Active Plus
Advantage South
APM Workcare
Body in Motion
Canterbury DHB (Burwood Hospital)
Capital and Coast DHB (Wellington)
Fit For Work
Futureproof Rehab
Habit Group
Hutt Valley DHB
Integrative Pain Care
Nelson Nursing Service
Occupational Health Canterbury
Pain Management and Rehabilitation Services Ltd
Pain Rehabilitation Christchurch Ltd
Proactive Health
QE Health
Southern Rehab
Taranaki DHB
TBI Health
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Paediatric pain management services
New South Wales

Victoria

Children’s Hospital at Westmead
John Hunter Children’s Hospital
Sydney Children’s Hospital Randwick

Monash Children’s Hospital
Royal Children’s Hospital Melbourne

Queensland

Starship Children’s Hospital Auckland

Queensland Children’s Hospital
St Vincent’s Private Hospital Brisbane

New Zealand

South Australia
Women’s and Children’s Hospital Adelaide
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Appendix B – ePPOC assessment tools
The assessment tools used in ePPOC are:
• Brief Pain Inventory (BPI)
• Depression, Anxiety, Stress Scale (DASS)
• Pain Catastrophising Scale (PCS)
• Pain Self-Efficacy Questionnaire (PSEQ)
• Global Rating of Change (GRC)
• Work Productivity and Impairment (WPAI)
• CARRA Body Chart.
Each of these assessment tools are briefly described below.

Brief Pain Inventory 4
The BPI items used in the ePPOC dataset measure the severity of pain and the degree to which the pain
interferes with common activities of daily living. There are four pain severity questions, rated on a scale
of 0 to 10, where 0 = ‘No pain’ and 10 = ‘Pain as bad as you can imagine’. Patients are asked to rate their
average, worst and least pain over the last week, and their pain right now. Pain severity is calculated as
an average of these four items.
Severity bands for these items are:
• 0-4 = mild pain
• 5-6 = moderate pain
• 7-10 = severe pain
The IMMPACT group’s recommendations for assessing clinical significance for 0-10 numeric pain scales
are that a change of:
≥ 10% represents minimally important change
≥ 30% represents moderate clinically important change (ePPOC uses this category to identify
clinically significant improvement for average and worst pain)
≥ 50% represents substantial clinically important change.
The interference questions are rated on a scale of 0 to 10, where 0 = ‘Does not interfere’ and
10 = ‘Completely interferes’. The interference subscale is an average of the seven interference questions.
At least 4 of 7 questions must be completed for this subscale to be valid. The IMMPACT recommendation
for assessment of clinically significant change on the BPI interference scale is a change of 1 point over the
average of the 7 items 5.

4

Modified Brief Pain Inventory, reproduced with acknowledgement of the Pain Research Group, University of Texas,
MD Anderson Cancer Centre, USA

5

Dworkin, RH, et al 2008, ‘Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials:
IMMPACT Recommendations.’ The Journal of Pain, vol. 9, no. 2, pp 105-121.
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Depression Anxiety Stress Scales (DASS) 6
The DASS measures the negative emotional states of depression, anxiety and stress. Due to the large
number of questions in the full DASS (42 questions), the DASS21 is administered. This comprises 21
questions which are rated on a scale of 0 to 3, where 0 = ‘did not apply to me at all’, 1 = ‘applied to me to
some degree, or some of the time’, 2 = ‘applied to me to a considerable degree, or a good part of the
time’, or 3 = ‘applied to me very much, or most of the time’. Scores are multiplied by 2 to enable
comparison with the full-scale DASS42 for which norms exist.
For each subscale (Depression, Anxiety and Stress), the 7 items are summed and then multiplied by 2.
The test developers suggest that at least 6 of 7 items should be complete for each subscale to be
considered valid. Table 10 shows the range of scores associated with severity categories for each
subscale.
Table 10 DASS severity categories

Depression

Anxiety

Stress

0-9

0-7

0-14

Mild

10-13

8-9

15-18

Moderate

14-20

10-14

19-25

Severe

21-27

15-19

26-33

28+

20+

34+

Normal

Extremely Severe

Clinical significance on each of the DASS subscales is defined as a change of 5 or more points coupled
with a move to a different severity category.

Pain Catastrophising Scale (PCS) 7
The PCS measures a patient’s thoughts and feelings related to their pain. This includes three subscales
measuring the dimensions of Rumination, Magnification and Helplessness. The PCS comprises 13
questions (Rumination – 4 items, Magnification – 3 items, Helplessness – 6 items) which are rated on a
scale of 0 to 4, where 0 = ‘not at all’, 1 = ‘to a slight degree’, 2 = ‘to a moderate degree’, 3 = ‘to a great
degree’ and 4 = ‘all the time’. For each subscale, all items must be completed to be valid. For the total to
be valid, at least 12 of 13 items must be completed.
Severity bands for the PCS are:
• <20 = mild
• 20 to 30 = high
• >30 = severe.
Clinically significant change requires a change in score of 6 or more points, combined with movement to a
different severity category 8.
6

Lovibond, SH and Lovibond, PF 1995, Manual for the Depression Anxiety Stress Scales, Psychology Foundation
Monograph, Sydney, Australia.

7

Sullivan, MJL, et al 1995, ‘The Pain Catastrophizing Scale: Development and Validation’, Psychological Assessment,
vol. 7, num. 4, pp 524-532.
8

Sullivan, MJL, personal communication with Nicholas, MK July 2014.
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Pain Self-Efficacy Questionnaire (PSEQ) 9
The PSEQ measures how confident a patient is that he or she can do a range of activities despite their
pain. The PSEQ Total is a sum of scores from 10 questions which are rated on a scale from 0 = ‘Not
confident at all’ to 6 = ‘Completely confident’. At least 9 of 10 items must be complete for the PSEQ Total
to be valid. Higher scores represent greater pain self-efficacy.
Severity bands for the PSEQ are:
• <20 = severe
• 20 to 30 = moderate
• 31 to 40 = mild
• >40 = minimal impairment.
Clinically significant change is defined as a change in score of 7 or more points, combined with movement
to a different severity category 10.

Global Rating of Change 11
The Global Rating of Change questions were included as part of the ePPOC dataset in 2018. They are
asked in follow-up questionnaires only. The two questions are “Compared with before receiving
treatment at this pain management service, how would you describe yourself now overall?” and
“Compared with before receiving treatment at this pain management service, how would you describe
your physical abilities now?” Participants answer by indicating their response on a Likert scale from -3
(very much worse) to +3 (very much better).

Work Productivity and Impairment (WPAI) 12
WPAI outcomes are expressed as impairment percentages, with higher numbers indicating greater
impairment and less productivity. The work status of all patients is collected, based on the International
Consortium for Health Outcomes Measurement (ICHOM) categories. For patients who are employed,
the WPAI items allow calculation of the following outcomes:
•
•
•

% of time missed from work due to pain (absenteeism)
% work impairment while working due to pain (lost productivity)
% overall work impairment due to pain (taking into account absenteeism and lost
productivity).

For more information on the calculations used please see the ePPOC Australian and New Zealand Data
Dictionaries on the ePPOC website https://ahsri.uow.edu.au/eppoc/forms.

9

Nicholas, MK 1989, ‘Self-efficacy and chronic pain’, British Psychological Society, St. Andrews, Scotland.

10

Nicholas, MK, personal communication, July 2014.

11

Bartlett, A, Flett, P, Tardif, H and Hush, J 2017, Introducing a global measure of function and change in NSW pain
services, 37th ASM of the Australian Pain Society, Adelaide, Australia.

12

Reilly MC, Zbrozek AS, Dukes E 1993, ‘The validity and reproducibility of a work productivity and activity
impairment measure’, PharmacoEconomics, vol. 4, num. 5, pp 353-365.
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CARRA Body Chart 13
Patients identify the site/s they feel pain using body maps. For reporting, pain sites are categorised into
pain areas as follows:
Pain sites
Head

head and face

Neck

neck

Chest

chest

Back

upper back, mid back and low back

Leg

left and right thighs, left and right calves, left and right ankles

Arm/shoulder

left and right shoulders, left and right upper arms, left and right elbows, left and
right forearms, left and right wrists

Abdomen

abdomen

Hands

left and right hands

Feet

left and right feet

Pelvic

groin

Knee

left and right knees

Hip

left and right hips

13

Von Bayer CL, et al. 2011, ‘Pain charts (body maps or manikins) in assessment of location of paediatric pain’, Pain
Management, vol. 1 num. 1, pp 61-68. (Source: Childhood Arthritis and Rheumatology Research Alliance,
www.carragroup.org)
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Appendix C – PaedePPOC assessment
tools
Six standardised assessment tools have been chosen to measure patient outcomes and the impact of the
child’s pain on the parent/parent:
•
•
•
•
•
•

Modified Brief Pain Inventory - Pain severity questions
Faces of Pain Scale – Revised
Paediatric Quality of Life Inventory (PedsQL)
Functional Disability Inventory (FDI)
Bath Adolescent Pain – Pain-specific anxiety
Bath Adolescent Pain – Parent Impact Questionnaire (BAP-PIQ)

Pain Severity
The tool used to capture pain severity is dependent on the patient’s age. Children aged eight and above
use the Modified Brief Pain Inventory 14, whereas those aged 5-7 use the Faces of Pain Scale-Revised 15.
MODIFIED BRIEF PAIN INVENTORY (BPI) - Modified versions of the questions in the standard BPI are used
to assess pain in children aged eight and over, and obtain a parent proxy rating of the child’s pain for all
age groups.
FACES PAIN SCALE – REVISED - Children choose one of six faces showing increasing levels of pain, from
‘no pain’ to ‘very much pain’ which correspond numerically to 0, 2, 4, 6, 8, 10.
For both tools, questions are rated on a scale of 0 (‘No pain’) to 10 (‘Pain as bad as you can imagine’),
with patients asked their average, worst and least pain over the last week, and their pain right now.
Severity bands for these items are:
• 0-4 = mild pain
• 5-6 = moderate pain
• 7-10 = severe pain
The IMMPACT group’s recommendations for assessing clinical significance for 0-10 numeric pain scales
are that a change of:
≥ 10% represents minimally important change
≥ 30% represents moderate clinically important change
≥ 50% represents substantial clinically important change.
To determine whether the change experienced by patients at referral is clinically significant, the
improvement must be at least moderately clinically important, i.e. at least a 30% improvement.

14

Modified Brief Pain Inventory, reproduced with acknowledgement of the Pain Research Group, University of Texas,
MD Anderson Cancer Centre, USA

15

Hicks CL, von Baeyer CL, Spafford P, van Korlaar I, Goodenough B. The Faces Pain Scale—Revised: toward a
common metric in pediatric pain measurement. PAIN, 2001;93:173–83.
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Paediatric Quality of Life Inventory (PedsQL) 16
PaedePPOC uses the PedsQL Generic Core Scales to measure health-related quality of life. Parents and all
patients complete the age-appropriate version. Items are rated on a five point scale where 0=’Never’ [a
problem] and 4=’Almost always’ [a problem]. For 5-7 year olds the scale is clinician administered and
rated on a three point scale where 0=’Never’ [a problem], 2=’Sometimes’ [a problem] and 4=’Almost
always’ [a problem].
Results are reported as four scale scores (physical, emotional, social and school functioning) and two
summary scores (psychosocial and physical health), with higher scores indicating better health-related
quality of life.
Minimal clinically meaningful difference on the PedsQL is measured as a:
• 4.4 change in the child self-report total score
• 4.5 change in adult proxy-report total score.
For the PedsQL ‘Sleep’ item, clinically significant improvement is reported for patients with trouble
sleeping at least sometimes (sleep item score = 2). The improvement is classed as clinically significant if
the score for sleep is reduced by at least 50%.

Functional Disability Inventory (FDI) 17
The FDI is a 15 item assessment tool which asks patients whether they have had any physical trouble or
difficulty doing specified activities. Items are rated on a five point scale where 0=’No trouble’ and
4=’Impossible’.
Severity bands for the FDI are:
• 0-12 = No/minimal disability
• 13-29 = Moderate disability
• >29 = Severe disability
Clinically significant change is defined as a change of 5 or more points coupled with a change to a
different severity category.

16

Varni JW, Burwinkle TM, Seid M. The PedsQL as a pediatric patient-reported outcome: reliability and validity of the
PedsQL measurement model in 25,000 children. Expert Rev Pharmacoecon Outcomes Res 2005;5:705–18.

17

Walker LS, Greene JW. The Functional Disability Inventory (FDI): measuring a neglected dimension of child health
status. J Paediatric Psychol 1991;16:39–58.
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Bath Adolescent Pain Questionnaire – Pain-specific anxiety 18
Section 5 of the BAPQ asks patients about specific worries or concerns they have about their pain. There
are seven items rated on a five point scale of ‘Never’ to ‘Always’.

Bath Adolescent Pain – Parent Impact Questionnaire 19
The impact of the child’s pain on the parent is measured over eight subscales: depression, anxiety, childrelated catastrophising, self-blame and helplessness, partner relationship, leisure functioning, parental
behaviour and parental strain. All items are rated on a 5 point scale, ranging from 0 (never) to 4 (always).

18

Eccleston C, Jordan A, McCracken LM, Sleed M, Connell H, Clinch J. The Bath Adolescent Pain Questionnaire
(BAPQ): development and preliminary psychometric evaluation of an instrument to assess the impact of chronic pain
on adolescents. PAIN 2005;118:263–70.

19

Jordan A, Eccleston C, McCracken LM, Connell H, Clinch J. The Bath Adolescent Pain—Parental Impact
Questionnaire (BAP-PIQ): development and preliminary psychometric evaluation of an instrument to assess the
impact of parenting an adolescent with chronic pain. PAIN, 2008;137:478–87.
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